These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 5655488)
21. [Use of tolinase (tolazamide) in diabetes mellitus]. Genes SG; Grinchenko TS; Lobanovskaia LI Vrach Delo; 1969 Apr; 4():40-4. PubMed ID: 5373588 [No Abstract] [Full Text] [Related]
22. [The development of sulfonylurea late resistance]. Angeli I Med Klin; 1970 Feb; 65(7):306-9. PubMed ID: 4996930 [No Abstract] [Full Text] [Related]
23. The use and abuse of oral hypoglycemic agents. Sussman KE Rocky Mt Med J; 1967 Feb; 64(2):56-9. PubMed ID: 6045352 [No Abstract] [Full Text] [Related]
24. Standards of diabetic control. Duncan GG; Duncan TG Med Clin North Am; 1966 Sep; 50(5):1371-83. PubMed ID: 5971576 [No Abstract] [Full Text] [Related]
25. [Treatment with a new antidiabetic: glybenclamide]. Madsen SN; Persson I Ugeskr Laeger; 1970 Jan; 132(4):143-7. PubMed ID: 5442953 [No Abstract] [Full Text] [Related]
26. [Acetohexamide (Ordimel) in the treatment of diabetes mellitus]. Tjorstad KO Tidsskr Nor Laegeforen; 1967 Jul; 87(14):1277-9. PubMed ID: 6046773 [No Abstract] [Full Text] [Related]
27. Long-term results with oral hypoglycemic drugs. Moss JM; DeLawter DE J Am Geriatr Soc; 1973 Feb; 21(2):72-6. PubMed ID: 4688111 [No Abstract] [Full Text] [Related]
28. Tolinase--a new oral antidiabetic drug. Med Lett Drugs Ther; 1966 Sep; 8(19):77-8. PubMed ID: 5971398 [No Abstract] [Full Text] [Related]
30. [Study of oral hypoglycemic agents. VI. Comparative study on acute oral overload using tolbutamide and tolazamide in normal and diabetic subjects. Various aspects of the prolonged use of tolazamide in comparison with other sulfonylureas]. Pereira VG; Wajchenberg BL; Shnaider J Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):133-42. PubMed ID: 5322747 [No Abstract] [Full Text] [Related]
31. [Testing a new antidiabetic (Glibenclamid) in hospitalized and ambulatory diabetics]. Belser F; Brögli H; Constam G; Zollikofer H Schweiz Rundsch Med Prax; 1970 Apr; 59(16):598-601. PubMed ID: 4997187 [No Abstract] [Full Text] [Related]
32. Attempts to delay the progression of chemical diabetes. Jimenez JA; Oppermann W; De Lellis RH; Camerini-Dávalos RA Adv Metab Disord; 1970; 1():Suppl 1:421+. PubMed ID: 5446909 [No Abstract] [Full Text] [Related]
34. [Our experience with Daonil. A new oral hypoglycemic agent]. Rodriguez-Miñon JL; Arrieta F; Herrera JL Diabete; 1970; 18(3):164-5. PubMed ID: 5472233 [No Abstract] [Full Text] [Related]
35. The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal. Tsalikian E; Dunphy TW; Bohannon NV; Lorenzi M; Gerich JE; Forsham PH; Kane JP; Karam JH Diabetes; 1977 Apr; 26(4):314-21. PubMed ID: 849812 [TBL] [Abstract][Full Text] [Related]
36. Yet another sulphonylurea for late-onset diabetics. S Afr Med J; 1969 Aug; 43(32):973-4. PubMed ID: 5822219 [No Abstract] [Full Text] [Related]